| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2022 | Iversen ES, Lipton G, Hart SN, Lee KY, Hu C, Polley EC, Pesaran T, Yussuf A, LaDuca H, Chao E, Karam R, Goldgar DE, Couch FJ, Monteiro ANA. An integrative model for the comprehensive classification of BRCA1 and BRCA2 variants of uncertain clinical significance. Npj Genomic Medicine. 7: 35. PMID 35665744 DOI: 10.1038/s41525-022-00302-3 | 0.38 | |||
| 2020 | Biswas K, Lipton GB, Stauffer S, Sullivan T, Cleveland L, Southon E, Reid S, Magidson V, Iversen ES, Sharan SK. A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays. Npj Genomic Medicine. 5: 52. PMID 33293522 DOI: 10.1038/s41525-020-00158-5 | 0.324 | |||
| 2020 | Lyra PCM, Nepomuceno TC, de Souza MLM, Machado GF, Veloso MF, Henriques TB, Dos Santos DZ, Ribeiro IG, Ribeiro RS, Rangel LBA, Richardson M, Iversen ES, Goldgar D, Couch FJ, Carvalho MA, et al. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33087888 DOI: 10.1038/s41436-020-00991-0 | 0.322 | |||
| 2020 | Trabert B, Tworoger SS, O'Brien KM, Townsend MK, Fortner RT, Iversen ES, Hartge P, White E, Amiano P, Arslan AA, Bernstein L, Brinton LA, Buring JE, Dossus L, Fraser GE, et al. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Research. PMID 31932455 DOI: 10.1158/0008-5472.Can-19-2850 | 0.468 | |||
| 2019 | Reid BM, Permuth JB, Chen YA, Fridley BL, Iversen ES, Chen Z, Jim H, Vierkant RA, Cunningham JM, Barnholtz-Sloan JS, Narod S, Risch H, Schildkraut JM, Goode EL, Monteiro AN, et al. Genome-wide analysis of common copy number variation and epithelial ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30948450 DOI: 10.1158/1055-9965.Epi-18-0833 | 0.472 | |||
| 2019 | Fernandes VC, Golubeva VA, Di Pietro G, Shields C, Amankwah K, Nepomuceno TC, de Gregoriis G, Abreu RBV, Harro C, Gomes TT, Silva RF, Suarez-Kurtz G, Couch F, Iversen ES, Monteiro ANA, et al. Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation. The Journal of Biological Chemistry. PMID 30765603 DOI: 10.1074/Jbc.Ra118.005274 | 0.39 | |||
| 2018 | Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Iversen ES, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 | 0.42 | |||
| 2018 | Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Iversen ES, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 | 0.522 | |||
| 2018 | Hart SN, Hoskin T, Shimelis H, Moore RM, Feng B, Thomas A, Lindor NM, Polley EC, Goldgar DE, Iversen E, Monteiro ANA, Suman VJ, Couch FJ. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 29884841 DOI: 10.1038/S41436-018-0018-4 | 0.305 | |||
| 2018 | Guidugli L, Shimelis H, Masica DL, Pankratz VS, Lipton GB, Singh N, Hu C, Monteiro ANA, Lindor NM, Goldgar DE, Karchin R, Iversen ES, Couch FJ. Assessment of the Clinical Relevance of BRCA2 Missense Variants by Functional and Computational Approaches. American Journal of Human Genetics. PMID 29394989 DOI: 10.1016/J.Ajhg.2017.12.013 | 0.369 | |||
| 2018 | Couch F, Shimelis H, Hart S, Moore R, Thomas A, Lipton G, Iversen E. Abstract GS4-06: Cancer risks and response to targeted therapy associated with BRCA2 variants of uncertain significance Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Gs4-06 | 0.489 | |||
| 2016 | Woods NT, Baskin R, Golubeva V, Jhuraney A, De-Gregoriis G, Vaclova T, Goldgar DE, Couch FJ, Carvalho MA, Iversen ES, Monteiro AN. Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. Npj Genomic Medicine. 1. PMID 28781887 DOI: 10.1038/Npjgenmed.2016.1 | 0.388 | |||
| 2016 | Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 | 0.44 | |||
| 2016 | Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Iversen ES, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 | 0.356 | |||
| 2016 | Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Iversen ES, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 | 0.435 | |||
| 2016 | Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, ... ... Iversen ES, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 | 0.488 | |||
| 2016 | Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Iversen ES, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 | 0.503 | |||
| 2016 | Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Iversen ES, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 | 0.376 | |||
| 2015 | Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Iversen ES, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 | 0.463 | |||
| 2015 | Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Iversen ES, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B | 0.363 | |||
| 2015 | Scarbrough PM, Weber RP, Iversen ES, Brhane Y, Amos CI, Kraft P, Hung RJ, Sellers TA, Witte JS, Pharaoh P, Henderson BE, Gruber SB, Hunter DJ, Garber JE, Joshi AD, et al. A Cross-Cancer Genetic Association Analysis of the DNA repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast and Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26637267 DOI: 10.1158/1055-9965.Epi-15-0649 | 0.424 | |||
| 2015 | Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 | 0.427 | |||
| 2015 | Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Iversen ES, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 | 0.5 | |||
| 2015 | Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Iversen ES, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 | 0.51 | |||
| 2015 | Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Iversen ES, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 | 0.485 | |||
| 2015 | Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Iversen E, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 | 0.471 | |||
| 2015 | Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Iversen ES, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 | 0.531 | |||
| 2015 | Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Iversen ES, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 | 0.409 | |||
| 2015 | Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Iversen ES, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 | 0.458 | |||
| 2015 | Marks JR, Anderson KS, Engstrom P, Godwin AK, Esserman LJ, Longton G, Iversen ES, Mathew A, Patriotis C, Pepe MS. Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 435-41. PMID 25471344 DOI: 10.1158/1055-9965.Epi-14-1178 | 0.374 | |||
| 2015 | Couch FJ, Shimelis H, Schroeder A, Hu C, Hallberg E, Lipton G, Iversen E, Lindor NM. Abstract 4685: Characterization of variants of uncertain significance (VUS) in breast and ovarian cancer predisposition genes Cancer Research. 75: 4685-4685. DOI: 10.1158/1538-7445.Am2015-4685 | 0.511 | |||
| 2015 | Permuth-Wey J, Reid BM, Chen YA, Lin H, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode E, Iversen E, Pearce L, Pharoah PDP, Phelan C, et al. Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility Cancer Research. 75: 4635-4635. DOI: 10.1158/1538-7445.Am2015-4635 | 0.506 | |||
| 2015 | Reid BM, Permuth-Wey J, Chen YA, Lin H, Monteiro A, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode EL, Iversen E, Pearce L, Pharoah P, Phelan C, et al. Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk Cancer Research. 75: 4634-4634. DOI: 10.1158/1538-7445.Am2015-4634 | 0.524 | |||
| 2014 | Tang X, Lin CC, Spasojevic I, Iversen ES, Chi JT, Marks JR. A joint analysis of metabolomics and genetics of breast cancer. Breast Cancer Research : Bcr. 16: 415. PMID 25091696 DOI: 10.1186/S13058-014-0415-9 | 0.38 | |||
| 2014 | Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Iversen ES, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 | 0.347 | |||
| 2014 | Iversen ES, Lipton G, Clyde MA, Monteiro AN. Functional annotation signatures of disease susceptibility loci improve SNP association analysis. Bmc Genomics. 15: 398. PMID 24886216 DOI: 10.1186/1471-2164-15-398 | 0.418 | |||
| 2014 | Hoyo C, Daltveit AK, Iversen E, Benjamin-Neelon SE, Fuemmeler B, Schildkraut J, Murtha AP, Overcash F, Vidal AC, Wang F, Huang Z, Kurtzberg J, Seewaldt V, Forman M, Jirtle RL, et al. Erythrocyte folate concentrations, CpG methylation at genomically imprinted domains, and birth weight in a multiethnic newborn cohort. Epigenetics : Official Journal of the Dna Methylation Society. 9: 1120-30. PMID 24874916 DOI: 10.4161/Epi.29332 | 0.306 | |||
| 2014 | Carvalho RS, Abreu RBV, Velkova A, Marsillac S, Rodarte RS, Suarez-Kurtz G, Iversen ES, Monteiro ANA, Carvalho MA. Probing structure-function relationships in missense variants in the carboxy-terminal region of BRCA1 Plos One. 9. PMID 24845084 DOI: 10.1371/Journal.Pone.0097766 | 0.38 | |||
| 2014 | Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Iversen ES, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 | 0.514 | |||
| 2014 | Permuth-Wey J, Chen YA, Chen Z, Berchuck A, Chenevix-Trench G, Doherty J, Gayther S, Goode EL, Iversen E, Monteiro ANA, Pearce L, Pharoah PDP, Phelan CM, Pirie A, Ramus S, et al. Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk Cancer Research. 74: 946-946. DOI: 10.1158/1538-7445.Am2014-946 | 0.506 | |||
| 2013 | Schildkraut JM, Iversen ES, Akushevich L, Whitaker R, Bentley RC, Berchuck A, Marks JR. Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1709-21. PMID 23917454 DOI: 10.1158/1055-9965.Epi-13-0192 | 0.502 | |||
| 2013 | Vidal AC, Murphy SK, Murtha AP, Schildkraut JM, Soubry A, Huang Z, Neelon SEB, Fuemmeler B, Iversen E, Wang F, Kurtzberg J, Jirtle RL, Hoyo C. Associations between antibiotic exposure during pregnancy, birth weight and aberrant methylation at imprinted genes among offspring International Journal of Obesity. 37: 907-913. PMID 23609933 DOI: 10.1038/Ijo.2013.47 | 0.331 | |||
| 2013 | Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Iversen E, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 | 0.49 | |||
| 2013 | Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Iversen E, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 | 0.506 | |||
| 2013 | Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Iversen E, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 | 0.525 | |||
| 2013 | Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Iversen E, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 | 0.471 | |||
| 2013 | Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, ... ... Iversen E, et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 880-90. PMID 23462924 DOI: 10.1158/1055-9965.Epi-12-1030-T | 0.444 | |||
| 2013 | Sfakianos GP, Iversen ES, Whitaker R, Akushevich L, Schildkraut JM, Murphy SK, Marks JR, Berchuck A. Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues. Gynecologic Oncology. 129: 159-64. PMID 23274563 DOI: 10.1016/J.Ygyno.2012.12.030 | 0.356 | |||
| 2013 | Grant DJ, Hoyo C, Akushevich L, Iversen ES, Whitaker R, Marks J, Berchuck A, Schildkraut JM. Vitamin D receptor (VDR) polymorphisms and risk of ovarian cancer in Caucasian and African American women. Gynecologic Oncology. 129: 173-8. PMID 23262379 DOI: 10.1016/J.Ygyno.2012.12.027 | 0.413 | |||
| 2013 | Agurs-Collins T, Iversen ES, Perna F, Baljinnyam B. Abstract A49: GSTM1, GSTT1, GST polymorphisms, physical activity, and breast cancer risk in premenopausal women of European ancestry Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-A49 | 0.476 | |||
| 2013 | Lin H, Tsai Y, Chen YA, Chen Z, Qu X, Goode EL, Schildkraut J, Iversen E, Narod SA, Sellers TA, Phelan CM. Abstract 4839: SNP-SNP interactions in mitochondria-related pathways are associated with invasive Epithelial Ovarian Cancer (EOC) risk . Cancer Research. 73: 4839-4839. DOI: 10.1158/1538-7445.Am2013-4839 | 0.461 | |||
| 2013 | Chornokur G, Tyrer J, Lin H, Han G, Qu X, Zhihua C, Tsai Y, Goode EL, Cunningham JM, Iversen E, Ramus SJ, Berchuk A, Schildkraut JM, Monteiro A, Gayther SA, et al. Abstract 3644: Variation in transmembrane transport genes influence epithelial ovarian cancer risk and histopathologic subtype. Cancer Research. 73: 3644-3644. DOI: 10.1158/1538-7445.Am2013-3644 | 0.493 | |||
| 2012 | Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, et al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. 23: 1805-10. PMID 22961099 DOI: 10.1007/S10552-012-0059-Y | 0.479 | |||
| 2012 | Fridley BL, Chalise P, Tsai YY, Sun Z, Vierkant RA, Larson MC, Cunningham JM, Iversen ES, Fenstermacher D, Barnholtz-Sloan J, Asmann Y, Risch HA, Schildkraut JM, Phelan CM, Sutphen R, et al. Germline copy number variation and ovarian cancer survival. Frontiers in Genetics. 3: 142. PMID 22891074 DOI: 10.3389/Fgene.2012.00142 | 0.423 | |||
| 2012 | Raska P, Iversen E, Chen A, Chen Z, Fridley BL, Permuth-Wey J, Tsai YY, Vierkant RA, Goode EL, Risch H, Schildkraut JM, Sellers TA, Barnholtz-Sloan J. European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry. Plos One. 7: e35235. PMID 22590501 DOI: 10.1371/Journal.Pone.0035235 | 0.387 | |||
| 2012 | Kelemen LE, Wang Q, Dinu I, Vierkant RA, Tsai YY, Cunningham JM, Phelan CM, Fridley BL, Amankwah EK, Iversen ES, Berchuck A, Schildkraut JM, Goode EL, Sellers TA. Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma. Frontiers in Genetics. 3: 33. PMID 22461784 DOI: 10.3389/Fgene.2012.00033 | 0.453 | |||
| 2012 | Fridley BL, Jenkins GD, Tsai YY, Song H, Bolton KL, Fenstermacher D, Tyrer J, Ramus SJ, Cunningham JM, Vierkant RA, Chen Z, Chen YA, Iversen E, Menon U, Gentry-Maharaj A, et al. Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 529-36. PMID 22302016 DOI: 10.1158/1055-9965.Epi-11-0741 | 0.487 | |||
| 2012 | White KL, Schildkraut JM, Palmieri RT, Iversen ES, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, et al. Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Research. 72: 1064-9. PMID 22282663 DOI: 10.1158/0008-5472.Can-11-3512 | 0.551 | |||
| 2012 | Permuth-Wey J, Lin H, Tsai Y, Zhihua C, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock S, Cramer DW, Cunningham JM, Fenstermacher D, Fridley B, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, ... ... Iversen E, et al. Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study Cancer Research. 72: 2927-2927. DOI: 10.1158/1538-7445.Am2012-2927 | 0.453 | |||
| 2012 | Raska P, Iversen ES, Chen A, Chen Z, Fridley BL, Permuth-Wey J, Tsai Y, Vierkant RA, Goode EL, Risch H, Schildkraut JM, Sellers TA, Barnholtz-Sloan J. Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data Cancer Research. 72: 1678-1678. DOI: 10.1158/1538-7445.Am2012-1678 | 0.395 | |||
| 2012 | Tsai Y, Monteiro ANA, Phelan CM, Iversen E, Fridley BL, Chen YA, Chen Z, Permuth-Wey J, Jim HS, Vierkant RA, Cunningham JM, Barnholtz-Sloan J, August A, Sutphen R, Narod S, et al. Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility Cancer Research. 72: 1649-1649. DOI: 10.1158/1538-7445.Am2012-1649 | 0.505 | |||
| 2011 | Moorman PG, Myers ER, Schildkraut JM, Iversen ES, Wang F, Warren N. Effect of hysterectomy with ovarian preservation on ovarian function Obstetrics and Gynecology. 118: 1271-1279. PMID 22067716 DOI: 10.1097/Aog.0B013E318236Fd12 | 0.311 | |||
| 2011 | Amankwah EK, Wang Q, Schildkraut JM, Tsai YY, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Dale LC, Lambrechts D, Amant F, Despierre E, ... ... Iversen ES, et al. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. Plos One. 6: e19642. PMID 21637745 DOI: 10.1371/Journal.Pone.0019642 | 0.49 | |||
| 2011 | Permuth-Wey J, Chen Z, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock SJ, Cramer DW, Cunningham JM, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, ... ... Iversen E, et al. MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1793-7. PMID 21636674 DOI: 10.1158/1055-9965.Epi-11-0397 | 0.509 | |||
| 2011 | Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, ... ... Iversen E, et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Research. 71: 3896-903. PMID 21482675 DOI: 10.1158/0008-5472.Can-10-4167 | 0.472 | |||
| 2011 | Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Sutphen R, et al. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1131-45. PMID 21447778 DOI: 10.1158/1055-9965.Epi-10-1224 | 0.422 | |||
| 2011 | Iversen ES, Couch FJ, Goldgar DE, Tavtigian SV, Monteiro AN. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1078-88. PMID 21447777 DOI: 10.1158/1055-9965.Epi-10-1214 | 0.405 | |||
| 2011 | Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, ... ... Iversen ES, et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics. 20: 2263-72. PMID 21422097 DOI: 10.1093/Hmg/Ddr087 | 0.53 | |||
| 2011 | Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Iversen ES, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 | 0.516 | |||
| 2011 | Matsumura N, Huang Z, Mori S, Baba T, Fujii S, Konishi I, Iversen ES, Berchuck A, Murphy SK. Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer Genome Research. 21: 74-82. PMID 21156726 DOI: 10.1101/Gr.108803.110 | 0.355 | |||
| 2011 | Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, ... ... Iversen ES, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 128: 2063-74. PMID 20635389 DOI: 10.1002/Ijc.25554 | 0.546 | |||
| 2011 | Chen YA, Chen Z, Tsai Y, Qu X, Iversen E, Barnholtz-Sloan J, Fridley BL, Permuth-Wey J, Risch H, Cunningham JM, Vierkant RA, Fenstermacher D, Sutphen R, Phelan CM, Monteiro AN, et al. Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS) Cancer Research. 71: 4729-4729. DOI: 10.1158/1538-7445.Am2011-4729 | 0.494 | |||
| 2011 | Fridley BL, Jenkins GD, Tsai Y, Fenstermacher D, Schildkraut J, Sutphen R, Chen YA, Iversen E, Vierkant RA, Cunningham JM, Chen Z, Sellers TA, Goode EL. Abstract 2738: Insights into survival from ovarian cancer revealed by gene set analysis Epidemiology. 71: 2738-2738. DOI: 10.1158/1538-7445.Am2011-2738 | 0.43 | |||
| 2010 | Wilson MA, Iversen ES, Clyde MA, Schmidler SC, Schildkraut JM. BAYESIAN MODEL SEARCH AND MULTILEVEL INFERENCE FOR SNP ASSOCIATION STUDIES. The Annals of Applied Statistics. 4: 1342-1364. PMID 21179394 DOI: 10.1214/09-Aoas322 | 0.425 | |||
| 2010 | Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Iversen ES, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 | 0.503 | |||
| 2010 | Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Iversen ES, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 | 0.49 | |||
| 2010 | Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, ... ... Iversen ES, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". Plos Genetics. 6: e1001016. PMID 20628624 DOI: 10.1371/Journal.Pgen.1001016 | 0.541 | |||
| 2010 | Bernardini MQ, Baba T, Lee PS, Barnett JC, Sfakianos GP, Secord AA, Murphy SK, Iversen E, Marks JR, Berchuck A. Expression signatures of TP53 mutations in serous ovarian cancers. Bmc Cancer. 10: 237. PMID 20504346 DOI: 10.1186/1471-2407-10-237 | 0.397 | |||
| 2010 | Schildkraut JM, Iversen ES, Wilson MA, Clyde MA, Moorman PG, Palmieri RT, Whitaker R, Bentley RC, Marks JR, Berchuck A. Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer. Plos One. 5: e10061. PMID 20386703 DOI: 10.1371/Journal.Pone.0010061 | 0.469 | |||
| 2010 | Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, et al. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Research and Treatment. 124: 441-51. PMID 20309627 DOI: 10.1007/S10549-010-0842-Y | 0.387 | |||
| 2010 | White KL, Sellers TA, Fridley BL, Vierkant RA, Phelan CM, Tsai YY, Kalli KR, Berchuck A, Iversen ES, Hartmann LC, Liebow M, Armasu S, Fredericksen Z, Larson MC, Duggan D, et al. Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 13: 43-56. PMID 20158306 DOI: 10.1375/Twin.13.1.43 | 0.493 | |||
| 2010 | Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, ... ... Iversen ES, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 | 0.548 | |||
| 2010 | Peedicayil A, Vierkant RA, Hartmann LC, Fridley BL, Fredericksen ZS, White KL, Elliott EA, Phelan CM, Tsai YY, Berchuck A, Iversen ES, Couch FJ, Peethamabaran P, Larson MC, Kalli KR, et al. Risk of ovarian cancer and inherited variants in relapse-associated genes. Plos One. 5: e8884. PMID 20111712 DOI: 10.1371/Journal.Pone.0008884 | 0.514 | |||
| 2010 | Tsai Y, Chen YA, Chen Z, Permuth-Wey J, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Fenstermacher D, Sutphen R, Phelan CM, Narod SA, Schildkraut JM, et al. Abstract 4724: A novel region on 8q24.21 is associated with ovarian cancer susceptibility Cancer Research. 70: 4724-4724. DOI: 10.1158/1538-7445.Am10-4724 | 0.532 | |||
| 2010 | Peedicayil A, Vierkant RA, Hartmann LC, Fridley BL, Fredericksen ZS, White KL, Elliott EA, Phelan CM, Tsai Y, Berchuck A, Iversen ES, Couch FJ, Peethambaram PP, Larson MC, Kalli KR, et al. Abstract 4718: Inherited variants in relapse-associated genes and risk of ovarian cancer Cancer Research. 70: 4718-4718. DOI: 10.1158/1538-7445.Am10-4718 | 0.56 | |||
| 2010 | Amankwah EK, Wang Q, Tsai Y, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Phelan CM, Cunningham JM, Vachon CM, Vierkant RA, Iversen ES, Berchuck A, Schildkraut JM, et al. Abstract 2854: Genetic variation in stromal genes decorin and lumican and susceptibility to serous ovarian cancer Cancer Research. 70: 2854-2854. DOI: 10.1158/1538-7445.Am10-2854 | 0.486 | |||
| 2009 | Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... ... Iversen ES, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424 | 0.53 | |||
| 2009 | Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, Barnett JC, Boren T, Murphy SK, Dressman HK, Marks JR, et al. Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2448-55. PMID 19318476 DOI: 10.1158/1078-0432.Ccr-08-2430 | 0.426 | |||
| 2009 | Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, ... ... Iversen ES, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138 | 0.547 | |||
| 2009 | Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, et al. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 69: 2349-57. PMID 19276375 DOI: 10.1158/0008-5472.Can-08-2902 | 0.538 | |||
| 2009 | Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, ... ... Iversen ES, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer. 100: 412-20. PMID 19127255 DOI: 10.1038/Sj.Bjc.6604820 | 0.536 | |||
| 2009 | Pearce CL, Near AM, Berg DJVD, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, ... ... Iversen ES, et al. Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com) British Journal of Cancer. 101: 1805-1805. DOI: 10.1038/Sj.Bjc.6605431 | 0.489 | |||
| 2008 | Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3567-72. PMID 19064572 DOI: 10.1158/1055-9965.Epi-08-0548 | 0.542 | |||
| 2008 | Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model. Human Mutation. 29: 1265-72. PMID 18951437 DOI: 10.1002/Humu.20897 | 0.382 | |||
| 2008 | Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, Halabi S, Berchuck A, Schildkraut JM. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women American Journal of Epidemiology. 167: 1059-1069. PMID 18303003 DOI: 10.1093/Aje/Kwn006 | 0.432 | |||
| 2008 | Sellers TA, Huang Y, Cunningham J, Goode EL, Sutphen R, Vierkant RA, Kelemen LE, Fredericksen ZS, Liebow M, Pankratz VS, Hartmann LC, Myer J, Iversen ES, Schildkraut JM, Phelan C. Association of single nucleotide polymorphisms in glycosylation genes with risk of epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 397-404. PMID 18268124 DOI: 10.1158/1055-9965.Epi-07-0565 | 0.529 | |||
| 2007 | Iversen ES, Katki HA, Chen S, Berry DA, Parmigiani G. Limited family structure and breast cancer risk. Jama. 298: 2007; author reply 2. PMID 17986693 DOI: 10.1001/Jama.298.17.2007-A | 0.359 | |||
| 2007 | Easton DF, Deffenbaugh AM, Pruss D, Frye C, Wenstrup RJ, Allen-Brady K, Tavtigian SV, Monteiro AN, Iversen ES, Couch FJ, Goldgar DE. A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. American Journal of Human Genetics. 81: 873-83. PMID 17924331 DOI: 10.1086/521032 | 0.465 | |||
| 2007 | Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, et al. Validity of models for predicting BRCA1 and BRCA2 mutations. Annals of Internal Medicine. 147: 441-50. PMID 17909205 DOI: 10.7326/0003-4819-147-7-200710020-00002 | 0.356 | |||
| 2007 | Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Iversen ES, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 | 0.514 | |||
| 2007 | Schildkraut JM, Murphy SK, Palmieri RT, Iversen E, Moorman PG, Huang Z, Halabi S, Calingaert B, Gusberg A, Marks JR, Berchuck A. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 473-80. PMID 17372242 DOI: 10.1158/1055-9965.Epi-06-0868 | 0.474 | |||
| 2006 | Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 863-71. PMID 16484695 DOI: 10.1200/Jco.2005.03.6772 | 0.338 | |||
| 2005 | Iversen ES, Chen S. Population-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer Genes. Journal of the American Statistical Association. 100: 399-409. PMID 18418465 DOI: 10.1198/016214505000000196 | 0.385 | |||
| 2005 | Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Research. 65: 4051-8. PMID 15899794 DOI: 10.1158/0008-5472.Can-04-3936 | 0.358 | |||
| 2005 | Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, Lee P, Murphy S, Dressman HK, Febbo PG, West M, Nevins JR, Marks JR. Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 3686-96. PMID 15897565 DOI: 10.1158/1078-0432.Ccr-04-2398 | 0.399 | |||
| 2005 | Zhou X, Iversen ES, Parmigiani G. Classification of missense mutations of disease genes Journal of the American Statistical Association. 100: 51-60. DOI: 10.1198/016214504000001817 | 0.359 | |||
| 2004 | Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, Milano CA, Rigat F, Pittman J, Nevins JR, West M, Goldschmidt-Clermont PJ. Gene expression phenotypes of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 24: 1922-7. PMID 15297278 DOI: 10.1161/01.Atv.0000141358.65242.1F | 0.34 | |||
| 2004 | Pittman J, Huang E, Dressman H, Horng CF, Cheng SH, Tsou MH, Chen CM, Bild A, Iversen ES, Huang AT, Nevins JR, West M. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proceedings of the National Academy of Sciences of the United States of America. 101: 8431-6. PMID 15152076 DOI: 10.1073/Pnas.0401736101 | 0.368 | |||
| 2004 | Berchuck A, Iversen ES, Lancaster JM, Dressman HK, West M, Nevins JR, Marks JR. Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays. American Journal of Obstetrics and Gynecology. 190: 910-25. PMID 15118612 DOI: 10.1016/J.Ajog.2004.02.005 | 0.425 | |||
| 2003 | Huang E, Cheng SH, Dressman H, Pittman J, Tsou MH, Horng CF, Bild A, Iversen ES, Liao M, Chen CM, West M, Nevins JR, Huang AT. Gene expression predictors of breast cancer outcomes. Lancet (London, England). 361: 1590-6. PMID 12747878 DOI: 10.1016/S0140-6736(03)13308-9 | 0.385 | |||
| 2002 | Berry DA, Iversen ES, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes Journal of Clinical Oncology. 20: 2701-2712. PMID 12039933 DOI: 10.1200/Jco.2002.05.121 | 0.401 | |||
| 2000 | Iversen ES, Parmigiani G, Berry DA, Schildkraut JM. Genetic Susceptibility and Survival: Application to Breast Cancer Journal of the American Statistical Association. 95: 28-42. DOI: 10.1080/01621459.2000.10473896 | 0.431 | |||
| 1998 | Claus EB, Schildkraut J, Iversen ES, Berry D, Parmigiani G. Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history Journal of the National Cancer Institute. 90: 1824-1829. PMID 9839523 DOI: 10.1093/Jnci/90.23.1824 | 0.438 | |||
| Show low-probability matches. | |||||